共 50 条
- [1] Thalidomide shows promise in previously untreated and refractory multiple myelomaCLINICAL LYMPHOMA, 2001, 2 (01): : 16 - 17不详
- [2] Bortezomib for previously untreated multiple myelomaEXPERT REVIEW OF HEMATOLOGY, 2011, 4 (04) : 381 - 398de la Rubia, JavierRoig, Monica
- [3] Bortezomib for previously untreated multiple myelomaEXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (16) : 2553 - 2564Delforge, Michel
- [4] Bortezomib for the treatment of previously untreated multiple myelomaIMMUNOTHERAPY, 2013, 5 (04) : 327 - 352Romano, AlessandraConticello, ConcettaDi Raimondo, Francesco
- [5] Role of bortezomib for the treatment of previously untreated multiple myelomaEXPERT REVIEW OF HEMATOLOGY, 2008, 1 (01) : 17 - 28Mateos, Maria-Victoria
- [6] COST EFFECTIVENESS ANALYSIS OF BORTEZOMIB IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA PATIENTS IN CANADAVALUE IN HEALTH, 2009, 12 (07) : A272 - A272Yoong, K.Attard, C.Jivraj, F.Shustik, C.Reece, D.
- [8] Bortezomib therapy alone and in combination with dexamethasone for patients with previously untreated multiple myeloma.BLOOD, 2005, 106 (11) : 231A - 231AJagannath, SDurie, BWolf, JCamacho, EIrwin, DLutzky, JMcKinley, MGabayan, EMazumder, ACrowley, JVescio, RSchenkein, D
- [9] Cost-Effectiveness Of Lenalidomide and Bortezomib In Patients With Previously Untreated Multiple Myeloma (MM)BLOOD, 2013, 122 (21)Oster, GerryBerger, ArielBornheimer, RebeccaBinder, GaryNagarwala, Yasir
- [10] Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myelomaHEMATOLOGY, 2007, 12 (03) : 235 - 239Wang, M.Giralt, S.Delasalle, K.Handy, B.Alexanian, R.